1Patel T. Increasing incidence and mortality of primary intrahepaticcholangiocarcinoma in the United States. Hepatology, 2001 ( 33 ):1353 -1357. 被引量：1
2Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis andstaging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 2011(8)..512 -522. 被引量：1
3S, Yamasaki. Intrahepatic cholangiocarcinoma : macroscopic type andstage classification, J. Hepatobiliary Pancreat. Surg, 10 ( 2003 ) 288-291. 被引量：1
4R. L. Siegel, K. D. Miller, A. Jemal. Cancer statistics, 2015 , CACancer J. Clin, 65 (2015) 5 -29. 被引量：1
5Y. H. Shaib, J. A. Davila, K. McGlynn, et al. Rising incidence ofintrahepatic cholangiocarcinoma in the United States : a true in-crease? ,J Hepatol, 40 (2004) 472 -477. 被引量：1
6T. Patel. Worldwide trends in mortality from biliary tract malignan-cies, BMC Cancer, 2 (2002) 10. 被引量：1
7S. A. Khan, S. D. Taylor-Robinson, M- B. Toledano,et al. Chan-ging international trends in mortality rates for liver, biliary and pan-creatic tumours, J. Hepatol, 37 (2002) 806 -813. 被引量：1
8S. A. Khan, M. B. Toledano, S. D. Taylor-Robinson. Epidemiolo-gy ,risk factors, and pathogenesis of cholangiocarcinoma,HPB ( Ox-ford) ,10 (2008) 77 -82. 被引量：1
9S. A. Khan, S. Emadossadaty, N. G. Ladep,et al. Rising trends incholangiocarcinoma: is the ICD classification system misleading us,J. Hepatol, 56 (2012) 848 -854. 被引量：1
10R. R. Plentz, N. P. Malek. Clinical presentation, risk factors andstaging systems of cholangiocarcinoma, Best Pract. Res. Clin. Gas-troenterol, 29 (2015) 245 -252. 被引量：1
2Liu-Bin Shi~1 Shu-You Peng~1 Xing-Kai Meng~1 Cheng-Hong Peng~1 Ying-Bin Liu~1 Xiao-Peng Chen~1 Zhen-Ling Ji~2 De-Tong Yang~2 Huai-Ren Chen~2 1 Department of Surgery,The Second Affiliated hospital of Zhejiang University School of Medicine,Hangzhou 310009,China2 Department of Surgery,Affiliated Zhongda Hospital of Southeast University,Nanjing 210009,China.Diagnosis and treatment of congenital choledochal cyst: 20 years' experience in China[J].World Journal of Gastroenterology,2001,7(5):732-734. 被引量：19
